Search clinical trials for: 3 weeks Dose Induction of Everolimus

Total 1218 results

University of California, San Francisco
Novartis

Terminated

Everolimus With and Without Temozolomide in Adult Low Grade Glioma

Low Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed Oligoastrocytomas

United States
KeyBioscience AG
Nordic Bioscience A/S

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
GlaxoSmithKline

Completed

An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

Carcinoma, Renal Cell

United Kingdom
University of Michigan Rogel Cancer Center

Completed

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Glioma

United States
Mclean Hospital
Solvay Pharmaceuticals

Completed

AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment

Depressive Disorder, Major

United States, Israel
Rovi Pharmaceuticals Laboratories

Recruiting

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (QUARTZ)

Schizophrenia

Jordan
Novartis Pharmaceuticals

Completed

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Kidney Transplantation

Germany, Switzerland
St. Jude Children's Research Hospital

Completed

Therapy for Pediatric Hodgkin Lymphoma

Hodgkin Lymphoma

United States
AbbVie
AbbVie

Recruiting

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)

Neovascular Age-Related Macular Degeneration (nAMD)

United States
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Hepatocellular Carcinoma | Solid Tumor, Adult

China
Indiana University
The National Center for Complementary and Integrative Health

Recruiting

Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus

Kidney Disease, Chronic | CBD | Transplant Complication

United States
Novartis Pharmaceuticals

Completed

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients (CERTITEM)

Renal Interstitial Fibrosis

France
Ohio State University

Completed

Basal Insulin Strategies Before Surgery

Type2 Diabetes Mellitus
Sanofi Pasteur, a Sanofi Company

Completed

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

Pneumonia | Pneumococcal Infections | Streptococcus Pneumoniae Infections

Bangladesh
University of Arizona
Amgen

Completed

Study of TVEC in Patients With Cutaneous Squamous Cell Cancer

Skin Cancer | Squamous Cell Carcinoma | Keratoacanthoma | Cutaneous Tumor | Skin Cancer, Squamous Cell | Lesion Skin

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions

Healthy

United States
University Hospital Center of Martinique
National Cancer Institute, France; GIRCI SOHO; Laboratoire de Psychologie des... and other collaborators

Recruiting

Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder (PICOC)

Cocaine Use Disorder

Martinique
Hamilton Health Sciences Corporation
The Physicians' Services Incorporated Foundation

Completed

Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

Venous Thrombosis | Atrial Fibrillation | Heart Valve Diseases

Canada
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Brown University; University of Southern California; Weill... and other collaborators

Recruiting

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Breast Cancer | Rare Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC

Non-Small Cell Lung Cancer

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions

Healthy

United States
Stanford University
Santen Inc.

Withdrawn

Intravitreal Sirolimus as Therapeutic Approach to Uveitis (SAVE-2)

Panuveitis | Uveitis | Posterior Uveitis | Intermediate Uveitis

United States
MorphoSys AG
Clinigen Healthcare Ltd

Approved for marketing

Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL

DLBCL
Clarus Therapeutics, Inc.
Celerion; Syneos Health; ARUP Laboratories

Completed

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

Hypogonadism, Male

United States
University of Texas Southwestern Medical Center

Terminated

A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients

Melanoma

United States
University Hospital, Caen

Unknown

E-NOSE for Breath Gas Analysis Under Microgravity Conditions (E-NOSE)

Healthy Volunteers

France
University of California, Los Angeles
AppliedVR Inc.

Withdrawn

Coronary Angiography THerapeutic Virtual Reality (CATH-VR)

Coronary Artery Disease | Atherosclerosis | Anxiety | Pain, Acute | Virtual Reality | Vasospasm;Peripheral
Shahid Beheshti University of Medical Sciences

Completed

Comparison of Safety and Efficacy of de Novo Everolimus

Cytomegalovirus Infections

Iran, Islamic Republic of
RayzeBio, Inc.

Recruiting

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

SCLC,Extensive Stage

United States
Brown University
Bristol-Myers Squibb; Rhode Island Hospital; Oncoceutics, Inc.

Terminated

BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (379)

Metastatic Colorectal Cancer

United States
CureVac

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies

Belgium, Germany
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Unknown

A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)

Small for Gestational Age Infant

China
Hadassah Medical Organization

Completed

Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors (rIL-2(LAK))

Metastatic Breast Cancer | Gastrointestinal Cancer | Renal Cell Cancer | Malignant Melanoma

Israel
Centre Leon Berard
NETRIS Pharma

Recruiting

Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] (AML-NET)

Acute Myeloid Leukemia Refractory

France
Odense University Hospital

Unknown

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer (Dual PETOvac)

Ovarian Cancer

Denmark
Boehringer Ingelheim

Completed

Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers

Healthy
University Hospital, Toulouse

Terminated

Study of Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery. (MUSCAADE)

Obesity

France
Jiandong Zhang

Recruiting

Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure (FL001)

Cancer Patients

China
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection

China
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection

China
Pfizer

Recruiting

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Shingles | Human | Herpes Zoster Infection

United States
Merck Sharp & Dohme LLC

Completed

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Arthritis, Rheumatoid
Centre Hospitalier Intercommunal Creteil

Recruiting

Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care

Sedation Complication | Mechanical Ventilation in Neonates

France
Fox Chase Cancer Center

Withdrawn

Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

Non-Small Cell Lung Cancer

United States
Institute for Clinical and Experimental Medicine

Recruiting

INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi (IDEAL)

Type 2 Diabetes Treated With Insulin

Czechia
Amgen

Completed

AMG 334 20160172 Pediatric Migraine PK Study.

Migraine

United States
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Platysmal Bands

United States
Benha University

Recruiting

Ultrasound Guided Pericapsular Nerve Block Versus iv Sedation Analgesia in Reduction of Shoulder Dislocation

Perioperative Pain

Egypt
LEO Pharma

Completed

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

Actinic Keratosis

Australia
Novartis Pharmaceuticals

Completed

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans (ATLAAST)

Hypertension

United States

Search clinical trials for: 3 weeks Dose Induction of Everolimus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations